RealClearHealth - Opinion, News, Analysis, Video and Polls

President Trump has decided to nominate White House aide Heidi Overton to lead the Food and Drug Administration, according to a senior... Read More

The Trump administration is taking credit for a 3.1% drop in drug prices since last year, a key metric ahead of the midterm elections. Read More

Richard Frank and Rachel Sachs provide the Senate Finance Committee with comments on policy options for lowering prescription drug prices. Read More

Big win here for Trump, but also for free market competition. Read More

Provider taxes, IGTs, and excessive SDPs do not create free resources for health care. They shift costs to federal taxpayers. Read More

When it comes to budgeting, Congress has two problems. Read More

One bipartisan bill deserves to move without delay: the ASAP Act, which would create a coverage pathway for new Alzheimer’s detection... Read More

By restricting new suppliers and shielding existing ones from competition, CON laws have made care more expensive and less accessible. Read More

Since becoming HHS secretary, RFK Jr. has presided over the highest number of measles cases in the last 35 years. Read More

For years, the Quantified Self movement had a stubborn problem: our devices became increasingly good at generating data but remained... Read More

Few symbols on food labels evoke such an immediate sense of health as the “organic seal.” Its promise of “natural”... Read More

Prescription drug prices do not become opaque by accident. They become opaque because the middlemen who manage drug benefits are allowed to... Read More

A unifying principle in health care has emerged over the last decade, with patients and policymakers alike demanding... Read More

The UK Covid-19 Inquiry has released the political chapters of its long-awaited report. After nearly three years, the conclusion is clear. Read More

Organizations are encouraged to support employees in developing good lifestyle habits to increase work engagement. Read More

I’ve seen clients start GLP-1 medications full of hope—and stop them feeling betrayed by their own biology. Read More

If the FDA policed only safety, not efficacy, the result would be more innovation at lower cost. Read More

The Alzheimer’s Policy Working Group is a 501(c)(3) organization that unites frontline clinicians from specialty and primary care to... Read More

On Thursday, January 22, the House Energy and Commerce Committee and the House Ways and Means Committee will each hold a hearing with some of... Read More

This is the fourth part of a series on the crisis in academic research and publishing. Read the first three parts here, here and here. By... Read More

Introduction In August, AHIP, the trade association for health insurance companies representing the industry’s top players, announced... Read More